Effects of Telemonitoring and Telemedicine Service for Type 2 Diabetes Care

NACompletedINTERVENTIONAL
Enrollment

417

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

December 31, 2013

Conditions
Type 2 Diabetes
Interventions
PROCEDURE

Telemonitoring group

The Telemonitoring group will be provided blood glucose meter, body composition analyzer, and remote monitoring PC. They should visit the site once per every 2 months (8 weeks), and measure their blood glucose using a provided blood glucose monitor twice a day during study period (once after first morning urination and once before going to bed). After measurement of blood glucose and body composition, the subjects should make transmit measured information through Smart Care PC into a centralized server of Smart Care Center. At Smart care Center, care manager will provide remote blood glucose monitoring and individual diabetes case management

PROCEDURE

Telemonitoring & Telemedicine

The Telemonitoring \& Telemedicine group will be provided blood glucose meter, body composition analyzer, and remote monitoring PC. They should measure their blood glucose using a provided blood glucose monitor twice a day during the study period. After measurement of blood glucose and body composition, the subjects should make transmit measured information through Smart Care PC into a centralized server of Smart Care Center. At Smart care Center, care manager will provide remote blood glucose monitoring and individual diabetes case management. A remote medical doctor should provide medical consultation to the subjects through videotelephony using the remote monitoring PC and then issue electronic prescriptions.

OTHER

SMBG

The subjects who are assigned in the control group will be provided blood glucose Monitor. The subjects who are assigned in the control group should perform the same blood glucose measurement same as the test group during the study, and measured results should be recorded in a diary of self blood glucose measurement. In addition, the subjects should visit the site once per every two months (8 weeks).

Trial Locations (4)

Unknown

Kyungpook National University Hospital, Daegu

Yeungnam University Medical Center, Daegu

Gangnam Severance Hospital, Seoul

Yonsei University Health System, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

LG Electronics Inc.

INDUSTRY

collaborator

Purdue University

OTHER

lead

CHANGHEE LEE

INDUSTRY

NCT01345435 - Effects of Telemonitoring and Telemedicine Service for Type 2 Diabetes Care | Biotech Hunter | Biotech Hunter